[go: up one dir, main page]

JP3110020B2 - Helicobacter pylori disinfectant - Google Patents

Helicobacter pylori disinfectant

Info

Publication number
JP3110020B2
JP3110020B2 JP11071594A JP7159499A JP3110020B2 JP 3110020 B2 JP3110020 B2 JP 3110020B2 JP 11071594 A JP11071594 A JP 11071594A JP 7159499 A JP7159499 A JP 7159499A JP 3110020 B2 JP3110020 B2 JP 3110020B2
Authority
JP
Japan
Prior art keywords
eradication
helicobacter pylori
cocoa
disinfectant
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP11071594A
Other languages
Japanese (ja)
Other versions
JP2000262246A (en
Inventor
晴彦 堤
卓 間藤
親造 玉田
優徳 亀井
佐藤  進
秀一 橋爪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga and Co Ltd
Original Assignee
Morinaga and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13465160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP3110020(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morinaga and Co Ltd filed Critical Morinaga and Co Ltd
Priority to JP11071594A priority Critical patent/JP3110020B2/en
Priority to KR10-2004-7009368A priority patent/KR100484328B1/en
Priority to DE60033019T priority patent/DE60033019D1/en
Priority to KR10-2001-7011667A priority patent/KR100509249B1/en
Priority to KR10-2004-7009367A priority patent/KR100484326B1/en
Priority to CNB008050821A priority patent/CN1262281C/en
Priority to CN 200510082409 priority patent/CN1714809A/en
Priority to PCT/JP2000/001635 priority patent/WO2000054792A1/en
Priority to EP00909702A priority patent/EP1170013B1/en
Priority to CN 200510082410 priority patent/CN1714810A/en
Publication of JP2000262246A publication Critical patent/JP2000262246A/en
Publication of JP3110020B2 publication Critical patent/JP3110020B2/en
Application granted granted Critical
Priority to US10/153,384 priority patent/US20020197342A1/en
Priority to US10/153,383 priority patent/US6488969B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、カカオマス中に含
まれるココア分を有効成分とするヘリコバクターピロリ
の除菌剤に関する。
The present invention relates to relates to a disinfectant of Helicobacter pylori as an active ingredient cocoa fraction contained in cacao mass.

【0002】[0002]

【従来の技術】ヘリコバクターピロリは、1983年オ
ーストラリアのWarrenとMarshallによっ
て慢性胃炎患者の胃粘膜から分離されたグラム陰性のら
せん状菌で、胃炎、十二指腸潰瘍患者より高率に分離さ
れることが報告されている。
BACKGROUND OF THE INVENTION Helicobacter pylori is a gram-negative spiral bacterium isolated from the gastric mucosa of patients with chronic gastritis by Warren and Marshall of Australia in 1983, and is reported to be isolated at a higher rate than patients with gastritis and duodenal ulcer. Have been.

【0003】そして本菌の感染は、急性胃炎、慢性胃炎
を引き起こすとともに、胃十二指腸潰瘍の再発因子及び
治癒遅延因子として作用することが知られており、除菌
することにより、胃十二指腸潰瘍の再発率(通常、1年
後に70〜80%が再発する)が激減する(再発率0〜
30%)ことが多くの研究者により報告されている。
[0003] Infection with this bacterium is known to cause acute gastritis and chronic gastritis, and also acts as a recurrence factor and a healing delay factor for gastroduodenal ulcer. The rate (usually 70-80% recurs after one year) drops dramatically (relapse rate 0-
30%) has been reported by many researchers.

【0004】ちなみに、わが国におけるヘリコバクター
ピロリの感染率は、年齢とともに上昇し、40歳代以上
では75%前後の高率を示している。
[0004] Incidentally, the infection rate of Helicobacter pylori in Japan increases with age, and is as high as about 75% in the age of 40 or older.

【0005】以上のように、ヘリコバクターピロリの除
菌は、消化性潰瘍の治療にとっては大きなメリットを有
しているが、その除菌方法はメリットの大きさと副作用
の大きさの関係から変化してきたのが現実である。
As described above, the eradication of Helicobacter pylori has great merit for treating peptic ulcer, but the eradication method has been changed due to the relationship between the merit and the side effect. That is the reality.

【0006】まず、1990年にシドニーで開催された
世界消化器病学会で推奨されたビスマス、テトラサイク
リン、メトロニダゾールの3剤併用療法は、除菌率が高
い(90%以上の除菌率)というメリットはあるが、副
作用の頻度も高く、服用を継続できない症例が多かっ
た。その後、アメリカでは1994年にNIH(Nat
ional Institute of Healt
h)の統一見解により、ヘリコバクターピロリ陽性の潰
瘍患者には、初発あるいは再発にかかわらず、酸分泌抑
制剤による治療に加えて、抗菌薬治療が必要であるとの
答申が発表された。その答申によれば、まず、酸分泌抑
制剤であるプロトンポンプ阻害剤(以下、PPIとい
う)と抗菌薬1剤の併用が副作用も少なく有効であるこ
とが報告された。しかし、この方法の除菌率は、必ずし
も高いものばかりではなく、十分と言えるものではない
ことから、抗菌薬の種類を色々と変えることが試みられ
ている。
[0006] First, the triple therapy of bismuth, tetracycline and metronidazole recommended by the World Gastroenterological Association held in Sydney in 1990 has the merit of high eradication rate (90% or more eradication rate). However, the frequency of side effects was high, and many patients could not continue taking the drug. Then, in the United States in 1994, NIH (Nat
ionical Institute of Health
According to the unified opinion in h), a report was issued that helicobacter pylori-positive ulcer patients, regardless of their onset or recurrence, require antimicrobial treatment in addition to treatment with acid secretion inhibitors. According to the report, it was first reported that the combined use of a proton pump inhibitor (hereinafter, referred to as PPI), which is an acid secretion inhibitor, and one antibacterial agent was effective with few side effects. However, since the eradication rate of this method is not always high and cannot be said to be sufficient, attempts have been made to change the type of antibacterial agent in various ways.

【0007】最近では、更に、抗菌薬をもう1剤追加し
て、PPIと2種類の抗菌薬の組合せが報告されている
が、その有効性と副作用についての評価はこれからとい
うのが現状である。
[0007] Recently, a combination of PPI and two kinds of antibacterial agents has been reported by further adding another antibacterial agent. However, the evaluation of the efficacy and side effects thereof is at present. .

【0008】一方、特開平11−1429号には、ペパ
ーミントオイル、スペアミントオイル、各種フレーバー
成分および各種天然素材抽出物より選択される少なくと
も1種を有効成分とする抗ヘリコバクター・ピロリ剤が
開示されている。そして、カオハスク、カカオニブから
エタノール抽出した抽出物が、ヘリコバクターピロリに
対して生育阻害作用を有するというin vitroの
実験結果が記載されている。
On the other hand, JP-A-11-1429 discloses an anti-Helicobacter pylori agent containing as an active ingredient at least one selected from peppermint oil, spearmint oil, various flavor components and various natural material extracts. I have. In addition, there is described an in vitro experimental result that an extract obtained by extracting ethanol from cao husk and cacao nib has a growth inhibitory effect on Helicobacter pylori.

【0009】しかしながら、特開平11−1429号に
は、カオハスク、カカオニブからエタノール抽出した抽
出物について、in vitroの実験結果しか示され
ておらず、臨床試験における効果は確認されていない。
また、同公報の試験例2においては、最も抗菌効果の高
かったカルダモンエタノール抽出液及びリモネンを併用
してヒトを用いた抗菌試験の結果が記載されているが、
それによって得られた除菌率35%という数値は、副作
用の心配がないという点では評価できるが、除菌率が低
すぎて有用性が低いと考えられる。
[0009] However, Japanese Patent Application Laid-Open No. H11-1429 shows only the in vitro experimental results of extracts obtained by extracting ethanol from cao husk and cacao nib, and no effect in clinical tests has been confirmed.
In addition, in Test Example 2 of the publication, the results of an antibacterial test using humans in combination with cardamom ethanol extract and limonene, which had the highest antibacterial effects, are described.
The numerical value of 35% of the eradication rate obtained thereby can be evaluated in that there is no concern about side effects, but it is considered that the eradication rate is too low and the usefulness is low.

【0010】[0010]

【発明が解決しようとする課題】上述したように、現時
点では100%の除菌効果と十分な安全性を兼ね備えた
除菌療法は確立されていない。このため、複雑で副作用
の多い多剤併用療法による治療を避け、できるだけシン
プルな方法で高い除菌効果が得られ、しかも副作用の少
ない除菌療法の確立が求められている。
As described above, at present, there is no established eradication therapy having both a 100% eradication effect and sufficient safety. Therefore, there is a demand for establishment of a eradication therapy which can avoid a complicated and multi-drug combination therapy having many side effects, obtain a high eradication effect by a method as simple as possible, and have few side effects.

【0011】本発明は、上記従来技術が抱える問題点を
踏まえ、副作用がなく安全で、手軽で、且つ栄養的に優
れたヘリコバクターピロリの除菌剤を提供することにあ
る。
An object of the present invention is to provide a safe, easy-to-use, and nutritionally-pure disinfectant for Helicobacter pylori, which has no side effects and has the above problems in the prior art.

【0012】[0012]

【課題を解決するための手段】上記目的を達成するた
め、本発明の1つは、カカオマス中に含まれるココア分
を有効成分として含有することを特徴とするヘリコバク
ターピロリの除菌剤を提供するものである。
Means for Solving the Problems In order to achieve the above object, one of the present invention is to provide a bactericide for Helicobacter pylori, which comprises a cocoa component contained in cocoa mass as an active ingredient. Things.

【0013】[0013]

【0014】本発明において、上記ココア分を含有する
ものとしては、ココア及び/又はカカオマスが好ましく
採用される。
In the present invention, cocoa and / or cocoa mass are preferably employed as those containing the cocoa component.

【0015】また、本発明のヘリコバクターピロリの除
菌剤においては、上記ココア分の他にヘリコバクターピ
ロリ除菌用抗生物質及び/又は酸分泌抑制剤を含有する
ことが好ましい。
The Helicobacter pylori eradication agent of the present invention preferably contains an antibiotic for eradication of Helicobacter pylori and / or an acid secretion inhibitor in addition to the cocoa component.

【0016】更に、本発明のヘリコバクターピロリの除
剤は、他の栄養源を含む食品中に添加して摂取するこ
ともでき、この場合の他の栄養源としては、タンパク
質、脂質、糖質、ビタミン及びミネラルを含有するもの
が好ましく採用される。
Furthermore, the Helicobacter pylori disinfectant of the present invention can be added to a food containing other nutrients and taken.
In this case, as other nutrients, those containing proteins, lipids, carbohydrates, vitamins and minerals are preferably employed.

【0017】本発明によれば、カカオマス中に含まれる
ココア分を有効成分とするので、副作用がなく安全で、
手軽で、且つ栄養的に優れたヘリコバクターピロリの
菌剤を提供することができる。また、ヘリコバクターピ
ロリ除菌用抗生物質及び/又は酸分泌抑制剤と併用する
ことにより、ヘリコバクターピロリの除菌率を飛躍的に
改善できるばかりでなく、従来の抗菌薬単独では除菌で
きなかったピロリ菌をも高率に除菌可能になるという効
果がもたらされる。また、カカオマス中に含まれるココ
ア分は、食物繊維以外の豊富な栄養成分や生理活性物質
を含んでいるので、栄養補給効果や健康維持効果ももた
らされる。
According to the present invention, cocoa contained in cacao mass is used as an active ingredient, so that it has no side effects and is safe.
Easy and nourishing Helicobacter pylori removal
A fungicide can be provided. In addition, the use of an antibiotic and / or an acid secretion inhibitor for eradication of Helicobacter pylori not only dramatically improves the eradication rate of Helicobacter pylori, but also eliminates the eradication of pylori that could not be eliminated by conventional antibacterial agents alone. The effect is obtained that bacteria can be removed at a high rate. In addition, the cocoa component contained in cacao mass contains abundant nutritional components and physiologically active substances other than dietary fiber, so that a nutritional supplementing effect and a health maintaining effect are also provided.

【0018】[0018]

【発明の実施形態】本発明において、ココア分とは、カ
カオマスからココアバターを除いた成分を意味し、主と
してタンパク質、糖質、食物繊維(水溶性難消化性多糖
類、ヘミセルロース、セルロース、リグニン等)、リン
脂質、無機質(リン、マグネシウム、カルシウム、鉄、
亜鉛、銅、カリウム、ナトリウム等)、ビタミンA、ビ
タミンB群、ビタミンC、ビタミンE(各種トコフェロ
ール等)、ナイアシン、シュウ酸、クエン酸、りんご
酸、コハク酸、乳酸、酢酸、タンニン、(エピカテキ
ン、カテキン、ケルセチン等のポリフェノール類)、無
水カフェイン、テオブロミン等を含有している。
DESCRIPTION OF THE PREFERRED EMBODIMENTS In the present invention, cocoa means a component obtained by removing cocoa butter from cacao mass, and is mainly composed of protein, carbohydrate, dietary fiber (water-soluble indigestible polysaccharide, hemicellulose, cellulose, lignin, etc.). ), Phospholipids, minerals (phosphorus, magnesium, calcium, iron,
Zinc, copper, potassium, sodium, etc.), vitamin A, vitamin B group, vitamin C, vitamin E (various tocopherols, etc.), niacin, oxalic acid, citric acid, malic acid, succinic acid, lactic acid, acetic acid, tannin, Catechin, catechin, polyphenols such as quercetin), anhydrous caffeine, theobromine and the like.

【0019】上記ココア分としては、例えば、カカオマ
スからココアバターを搾油して得られるココアパウダー
や、あるいはカカオマス自体が好ましく用いられる。
As the cocoa component, for example, cocoa powder obtained by pressing cocoa butter from cocoa mass or cocoa mass itself is preferably used.

【0020】本発明において、ヘリコバクターピロリ除
菌用抗生物質としては、例えばクラリスロマイシン等が
挙げられる。また、酸分泌抑制剤としては、プロトンポ
ンプ抑制剤(PPI)、H2ブロッカー(H2RA)等
が挙げられる。
In the present invention, the antibiotic for eradication of Helicobacter pylori includes, for example, clarithromycin and the like. Examples of the acid secretion inhibitor include a proton pump inhibitor (PPI) and an H2 blocker (H2RA).

【0021】上記ココア分と上記ヘリコバクターピロリ
除菌用抗生物質及び/又は酸分泌抑制剤とを併用投与す
ることにより、除菌効果をさらに高めることができる。
By co-administering the cocoa component and the antibiotic for helicobacter pylori eradication and / or the acid secretion inhibitor, the eradication effect can be further enhanced.

【0022】本発明のヘリコバクターピロリの除菌
は、上記ココア分と、他の栄養源とを含有する食品とし
て摂取することもできる。
Eradication of Helicobacter pylori of the present inventionAgent
Contains the above cocoa and other nutrient sourcesFood
You can also ingest.

【0023】上記他の栄養源としては、特に限定されな
いが、例えば乳蛋白、大豆蛋白等の蛋白質、植物性油脂
等の脂質、砂糖、デキストリン等の糖質、ビタミン類、
ミネラル類等が好ましく用いられる。
Examples of the other nutrient sources include, but are not limited to, proteins such as milk protein and soy protein, lipids such as vegetable oils and fats, sugars such as sugar and dextrin, vitamins, and the like.
Minerals and the like are preferably used.

【0024】また、本発明のヘリコバクターピロリの除
菌剤を含有する食品の形態は、特に限定されず、例え
ば、カカオマスやココアパウダーを原料として製造され
る各種の飲食品、例えばココアドリンク、調整ココア、
チョコレート等として製品化することもできる。
In addition, the present invention eliminates Helicobacter pylori of the present invention.
The form of the food containing the fungicide is not particularly limited, for example, various foods and drinks produced using cacao mass and cocoa powder as raw materials, for example, cocoa drink, adjusted cocoa,
It can be commercialized as chocolate or the like.

【0025】本発明のヘリコバクターピロリ除菌効果を
得るためには、上記ココア分をカカオマス換算で1日当
たり5g以上摂取することが望ましい。
In order to obtain the eradication effect of Helicobacter pylori of the present invention, it is desirable to ingest the cocoa component in an amount of 5 g or more per day in terms of cacao mass.

【0026】そのため、飲食品として、本発明のヘリコ
バクターピロリの除菌剤を摂取する場合には、上記飲食
品中に上記ココア分が、固形分換算で3.5〜10重量
%含有されていることが好ましい。
Therefore, in the case of ingesting the Helicobacter pylori disinfectant of the present invention as food or drink, the food or drink contains the cocoa component in an amount of 3.5 to 10% by weight in terms of solid content. Is preferred.

【0027】なお、本発明のヘリコバクターピロリの除
剤を食品として摂取する場合も、ヘリコバクターピロ
リ除菌用抗生物質及び/又は酸分泌抑制剤を併用して摂
取することが好ましく、それによって除菌効果をさらに
高めることができる。
[0027] Even when ingesting the disinfectant of Helicobacter pylori of the present invention as a food, it is preferable to ingest a combination of Helicobacter pylori antibiotic and / or an acid secretion inhibitor, whereby eradication The effect can be further enhanced.

【0028】[0028]

【実施例】以下、実施例を挙げて本発明を具体的に説明
する。 実施例1(調整ココア) ココアパウダー、砂糖、全粉乳、脱脂粉乳等の原料を粉
体混合して調製された市販の調整ココア(ミルクココ
ア)をヘリコバクターピロリの除菌剤として使用した。
この調整ココアの24g中の成分は表1に示すとおりで
あり、その熱量は95kcalであった。
The present invention will be specifically described below with reference to examples. Example 1 (Prepared Cocoa) A commercially available prepared cocoa (milk cocoa) prepared by mixing powders of raw materials such as cocoa powder, sugar, whole milk powder and skim milk powder was used as a disinfectant for Helicobacter pylori.
The components in 24 g of this prepared cocoa were as shown in Table 1, and the calorific value was 95 kcal.

【0029】[0029]

【表1】 [Table 1]

【0030】試験例1 ヘリコバクターピロリの除菌歴がない、胃及び/又は十
二指腸潰瘍の患者に対して、従来の除菌法を行いなが
ら、実施例で得たココアを併用投与して、その除菌効果
を調べた。
Test Example 1 To a patient with no history of eradication of Helicobacter pylori and suffering from stomach and / or duodenal ulcer, the cocoa obtained in the example was administered in combination with the conventional bactericidal method. The fungal effect was examined.

【0031】ここでいう従来の除菌法とは、酸分泌抑制
剤であるプロトンポンプ抑制剤(PPI)と、ヘリコバ
クターピロリ除菌用抗生物質であるクラリスロマイシン
(CAM、400mg/day)の併用投与を行った
後、PPIと、同じく酸分泌抑制剤であるH2ブロッカ
ー(以下、H2RAという)を併用投与する方法であ
る。
Here, the conventional eradication method is a combination of a proton pump inhibitor (PPI) as an acid secretion inhibitor and clarithromycin (CAM, 400 mg / day) as an antibiotic for eradication of Helicobacter pylori. This is a method in which after administration, PPI and an H2 blocker (hereinafter, referred to as H2RA), which is also an acid secretion inhibitor, are administered in combination.

【0032】具体的には、(PPI+CAM)投与を1
0日間行い、続いて1ヶ月以上PPI投与した後に、更
に続けてH2RAを投与後、ウレアーゼ法(U)、病理
検査法(P)及び培養試験法(C)を行い除菌判定を行
った。そして、このうち少なくともウレアーゼ法及び培
養試験法の2種類の検査が陰性であれば除菌が成功した
と判断した。
Specifically, (PPI + CAM) administration was
The administration was performed for 0 days, followed by administration of PPI for 1 month or more, followed by administration of H2RA, followed by the urease method (U), the pathological examination method (P), and the culture test method (C) to determine the eradication. Then, if at least two tests, the urease method and the culture test method, were negative, it was determined that the eradication was successful.

【0033】なお、ココアの投与は、実施例1で得た市
販の調整ココア約24gに約120mlのお湯を加えて
1杯分とし、上記除菌期間中、1日に1杯以上のココア
を飲用し続けることにより行った。その試験結果を表2
に示す。
The cocoa was administered by adding about 120 ml of hot water to about 24 g of the commercially prepared cocoa obtained in Example 1 to make one cup, and one or more cups of cocoa per day during the sterilization period. Performed by continuing to drink. Table 2 shows the test results.
Shown in

【0034】[0034]

【表2】 [Table 2]

【0035】表2の結果から、ココアを併用して摂取す
ることにより、この施設での従来除菌法の除菌率(約4
0%)に比べて高率(除菌率75%)にヘリコバクター
ピロリを除菌できることが明らかとなった。
From the results in Table 2, it can be seen that cocoa was ingested in combination, and the eradication rate of the conventional eradication method at this facility (about 4%).
0%), it was found that Helicobacter pylori could be disinfected at a higher rate (75%).

【0036】試験例2 従来の除菌法での除菌歴があるが、それでも除菌できな
かった患者に対して、試験例1と同様に従来の除菌法に
加えてココアを併用投与して、その除菌効果を調べた。
その結果を表3に示す。
Test Example 2 To a patient who had a history of eradication by the conventional eradication method but was still unable to eradicate, cocoa was administered in addition to the conventional eradication method as in Test Example 1. The eradication effect was examined.
Table 3 shows the results.

【0037】[0037]

【表3】 [Table 3]

【0038】表3の結果から、ココアを併用投与するこ
とにより、従来の除菌法だけでは除菌できなかった5人
の患者のうち、3人がヘリコバクターピロリを除菌する
ことができた。また、表2の結果と合わせて考えると、
従来の除菌法とココアの投与を併用することにより、従
来の除菌法の除菌率を大幅に改善できることを示してい
る。
From the results shown in Table 3, by coadministering cocoa, three out of five patients who could not be eradicated by the conventional elimination method alone were able to eradicate Helicobacter pylori. Considering the results in Table 2,
It shows that the combined use of cocoa and the conventional eradication method can significantly improve the eradication rate of the conventional eradication method.

【0039】試験例3 試験例1及び2とは異なり、ヘリコバクターピロリ除菌
用抗生物質を用いずに胃酸分泌抑制剤(PPI+H2R
A)とココアだけを6週間以上併用投与して除菌を試み
た。その結果を表4に示す。
Test Example 3 Unlike Test Examples 1 and 2, a gastric acid secretion inhibitor (PPI + H2R) was used without using an antibiotic for eradication of Helicobacter pylori.
A) and cocoa alone were administered in combination for 6 weeks or more to try to remove bacteria. Table 4 shows the results.

【0040】[0040]

【表4】 [Table 4]

【0041】表4に示されるように、2つの症例中1例
が除菌できた。この結果は、副作用がほとんどない除菌
の可能性を示している。
As shown in Table 4, one of the two cases was eradicated. This result indicates the possibility of eradication with almost no side effects.

【0042】[0042]

【発明の効果】以上説明したように、本発明によるヘリ
コバクターピロリの除菌剤によれば、簡便で且つ効果的
に従来の除菌法の除菌率を改善できるばかりでなく、従
来の除菌法では除菌が困難な患者に対しても除菌が可能
となる。
As described above , according to the Helicobacter pylori eradication agent of the present invention, not only can the eradication rate of the conventional eradication method be improved simply and effectively, but also the conventional eradication method can be used. The method allows eradication of patients who are difficult to eradicate.

【0043】また、ヘリコバクターピロリ除菌用抗生物
質を使用せずに、胃酸分泌抑制剤とココアのみでもヘリ
コバクターピロリの除菌が可能であるため、より副作用
も少なくなり、今まで副作用が原因で除菌が困難であっ
た患者に対しても除菌することができる。
In addition, the use of a gastric acid secretion inhibitor and cocoa alone enables the elimination of Helicobacter pylori without using an antibiotic for eradication of Helicobacter pylori, thereby reducing the number of side effects. Bacteria can be eliminated even for patients who have had difficulty in bacteria.

【0044】そして、カカオマス中に含まれるココア分
は、食物繊維以外にも豊富な栄養成分や生理活性物質を
含んでいるので、栄養補給効果や健康維持効果ももたら
される。
The cocoa content contained in cocoa mass contains abundant nutritional components and physiologically active substances in addition to dietary fiber, so that it has a nutritional supplementing effect and a health maintaining effect.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 佐藤 進 神奈川県横浜市鶴見区下末吉2−1−1 森永製菓株式会社 研究所内 (72)発明者 橋爪 秀一 神奈川県横浜市鶴見区下末吉2−1−1 森永製菓株式会社 研究所内 (56)参考文献 特開 平7−274894(JP,A) (58)調査した分野(Int.Cl.7,DB名) A23L 1/28 - 1/30 A61K 35/78 JICSTファイル(JOIS)────────────────────────────────────────────────── ─── Continuing on the front page (72) Susumu Sato 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama-shi, Kanagawa Prefecture Morinaga Confectionery Co., Ltd. (72) Inventor Shuichi Hashizume 2- Shimosueyoshi, Tsurumi-ku, Yokohama-shi, Kanagawa 1-1 Laboratory in Morinaga Seika Co., Ltd. (56) References JP-A-7-274894 (JP, A) (58) Fields investigated (Int. Cl. 7 , DB name) A23L 1/28-1/30 A61K 35/78 JICST File (JOIS)

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 カカオマス中に含まれるココア分を有効
成分として含有することを特徴とするヘリコバクターピ
ロリの除菌剤。
1. A bactericidal agent for Helicobacter pylori, which comprises a cocoa component contained in cacao mass as an active ingredient.
【請求項2】 ココア及び/又はカカオマスを含有する
ものである請求項1記載のヘリコバクターピロリの除菌
剤。
2. The disinfectant for Helicobacter pylori according to claim 1, which contains cocoa and / or cocoa mass.
【請求項3】 前記ココア分と、ヘリコバクターピロリ
除菌用抗生物質及び/又は酸分泌抑制剤とを有効成分と
して含有する請求項1又は2記載のヘリコバクターピロ
リの除菌剤。
3. The disinfectant for Helicobacter pylori according to claim 1 or 2, comprising the cocoa component and an antibiotic and / or acid secretion inhibitor for eradication of Helicobacter pylori as active ingredients.
JP11071594A 1999-03-17 1999-03-17 Helicobacter pylori disinfectant Expired - Fee Related JP3110020B2 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP11071594A JP3110020B2 (en) 1999-03-17 1999-03-17 Helicobacter pylori disinfectant
CN 200510082409 CN1714809A (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
EP00909702A EP1170013B1 (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
KR10-2001-7011667A KR100509249B1 (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
KR10-2004-7009367A KR100484326B1 (en) 1999-03-17 2000-03-17 Foods containing cocoa component
CNB008050821A CN1262281C (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
KR10-2004-7009368A KR100484328B1 (en) 1999-03-17 2000-03-17 Foods containing cocoa component
PCT/JP2000/001635 WO2000054792A1 (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
DE60033019T DE60033019D1 (en) 1999-03-17 2000-03-17 MEDICINES, FOODS, BEVERAGES AND FEED CONTAINING A COCOA COMPONENT
CN 200510082410 CN1714810A (en) 1999-03-17 2000-03-17 Drugs, foods, drinks and feeds containing cocoa component
US10/153,384 US20020197342A1 (en) 1999-03-17 2002-05-22 Method of wound healing
US10/153,383 US6488969B1 (en) 1999-03-17 2002-05-22 Method for reducing blood ammonia concentration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11071594A JP3110020B2 (en) 1999-03-17 1999-03-17 Helicobacter pylori disinfectant

Publications (2)

Publication Number Publication Date
JP2000262246A JP2000262246A (en) 2000-09-26
JP3110020B2 true JP3110020B2 (en) 2000-11-20

Family

ID=13465160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11071594A Expired - Fee Related JP3110020B2 (en) 1999-03-17 1999-03-17 Helicobacter pylori disinfectant

Country Status (2)

Country Link
JP (1) JP3110020B2 (en)
CN (2) CN1714810A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0577133U (en) * 1992-03-31 1993-10-19 太陽誘電株式会社 Chip circuit component supply device
WO2003099304A1 (en) 2002-05-27 2003-12-04 Morinaga & Co., Ltd. Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006033321A1 (en) * 2006-07-17 2008-01-24 Westfälische Wilhelms-Universität Münster Medical use of N-phenylpropenoyl amino acid derivatives and related compounds
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0577133U (en) * 1992-03-31 1993-10-19 太陽誘電株式会社 Chip circuit component supply device
WO2003099304A1 (en) 2002-05-27 2003-12-04 Morinaga & Co., Ltd. Composition against periodontal bacteria and foods, drinks and mouth washers against periodontal bacteria containing the composition

Also Published As

Publication number Publication date
CN1714810A (en) 2006-01-04
JP2000262246A (en) 2000-09-26
CN1714809A (en) 2006-01-04

Similar Documents

Publication Publication Date Title
KR19980702533A (en) Anti-obesity agent with procyanidin as active ingredient
EP0930019A2 (en) Composition for treating obesity and foods and drinks containing the same
KR100967040B1 (en) Anti-periodontic composition, anti-periodontic foods containing the anti-periodontic composition and cleaning agent for oral cavity
US20030118662A1 (en) Therapeutic uses of milk mineral fortified food products
JP2008237117A (en) Anti-fatigue food raw material and anti-fatigue food
CN101239091A (en) Composition for preventing and controlling helicobacter pylori affection
AU2002305703A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
EP1404351A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
CA2863880A1 (en) Eucommia ulmoides-containing chocolate compositions
JP3110020B2 (en) Helicobacter pylori disinfectant
EP2147677B1 (en) Eradicating agent for helicobacter pylori
US20050152852A1 (en) Use of antibacterial component extracted from cacao mass for inhibiting the growth of periodontal bacteria
JP5281895B2 (en) Calcium absorption promoter
US6488969B1 (en) Method for reducing blood ammonia concentration
US7371415B1 (en) Method and composition for improving sexual fitness
JPWO2005074961A1 (en) Body fat regulator
JP4982648B2 (en) Metal deposition inhibitor
US20030017219A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
US20020197342A1 (en) Method of wound healing
JP2002085012A (en) Food and drink against helicobacter pylori
JP3749647B2 (en) Blood ammonia reducing agent
WO2023287997A1 (en) Ilex paraguariensis extracts, compositions, and related methods
US20200360423A1 (en) Solid concentrated constipation treatment formulations
WO2002096451A1 (en) Carbohydrate modifying agent and drinks containing the modifying agent
CS209766B1 (en) Dietetic preparation

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080914

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080914

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090914

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090914

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100914

Year of fee payment: 10

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110914

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110914

Year of fee payment: 11

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120914

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120914

Year of fee payment: 12

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130914

Year of fee payment: 13

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees